New program aims to catch complications early in multiple myeloma patients after transplant
NCT ID NCT05947136
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a program called PASCA that helps doctors detect and manage complications like high blood pressure, kidney failure, chronic pain, and fatigue in multiple myeloma patients after a stem cell transplant. About 204 adults aged 18 to 70 will be randomly assigned to either the PASCA program or standard care. The goal is to see if proactive screening and early referrals improve long-term health outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PASCA program (behavioral intervention: screening and referral for complications)
- What this could lead to
- If successful, this program could help doctors catch and treat complications like high blood pressure, kidney problems, or fatigue earlier, improving quality of life for multiple myeloma patients after transplant.
- What could go wrong
- This is a Phase 3 trial, but it tests a care program, not a new drug. The benefit may be small, and results may not apply to all patients or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLICATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CENTRE HOSPITALIER UNIVERSITAIRE de MONTPELLIER
RECRUITINGMontpellier, 34295, France
-
CH Annecy Genevois
RECRUITINGÉpagny, 74370, France
-
CHU La Tronche
RECRUITINGGrenoble, 38300, France
-
CHU de St-Etienne
RECRUITINGSaint-Etienne, France
-
Centre Léon Bérard
RECRUITINGLyon, 69373, France
-
Le Centre Hôpitaux Nord-Ouest Villefranche-sur-Saône
RECRUITINGVillefranche-sur-Saône, 69655, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact